CytoReason is focused on turning human clinical data into clear biology in order to deliver data-driven target discovery and drug development. The company uses its access to proprietary and public data, combined with machine learning technologies, to create innovative biological models of diseases, tissues, and drugs. Using its molecular-level disease models, CytoReason turns human clinical data into biology, mapping what the cells, genes, and proteins are doing in disease, tissue, and treatment environments. This enables the company to uncover disease and drug mechanisms of action and to put that biology to clinical use by delivering valuable IP in the form of novel targets, indications, combinations, and biomarkers.

CytoReason (סיטוריזון)

CytoReason (סיטוריזון)